Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2019

Feb 14, 2020

SELL
$6.53 - $10.72 $104,480 - $171,520
-16,000 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$6.16 - $9.6 $160,160 - $249,600
-26,000 Reduced 61.9%
16,000 $110,000
Q2 2019

Aug 14, 2019

SELL
$8.12 - $15.72 $64,959 - $125,760
-8,000 Reduced 16.0%
42,000 $388,000
Q1 2019

May 15, 2019

SELL
$15.58 - $20.01 $662,150 - $850,425
-42,500 Reduced 45.95%
50,000 $784,000
Q4 2018

Feb 14, 2019

SELL
$14.59 - $23.84 $109,425 - $178,800
-7,500 Reduced 7.5%
92,500 $1.43 Million
Q3 2018

Nov 13, 2018

SELL
$21.06 - $25.65 $1.9 Million - $2.31 Million
-90,000 Reduced 47.37%
100,000 $2.15 Million
Q2 2018

Aug 14, 2018

SELL
$16.77 - $24.71 $922,350 - $1.36 Million
-55,000 Reduced 22.45%
190,000 $4.62 Million
Q1 2018

May 15, 2018

BUY
$16.68 - $22.07 $4.09 Million - $5.41 Million
245,000 New
245,000 $4.19 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $20.5B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Mkp Capital Management, L.L.C. Portfolio

Follow Mkp Capital Management, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mkp Capital Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Mkp Capital Management, L.L.C. with notifications on news.